Author: TERAMICHI, Takurou; FUKUSHI, Shuetsu; HACHIYA, Yuma; MELAKU, Simenew Keskes; OGUMA, Keisuke; SENTSUI, Hiroshi
Title: Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia Document date: 2019_11_5
ID: vijh6x1l_22
Snippet: A comparison of the two neutralization tests using VSV-MERS/GFP and MERS-CoV showed a high correlation between both antibody titers. The former showed an antibody titer of ≥256, whereas the latter showed an antibody titer of ≥512. S1-ELISA was not sensitive compared to other tests because only 16 serum samples were positive and they required an antibody titer of ≥64 in VSV-MERS/GFP. However, the sensitivity of S1-ELISA would be improved by .....
Document: A comparison of the two neutralization tests using VSV-MERS/GFP and MERS-CoV showed a high correlation between both antibody titers. The former showed an antibody titer of ≥256, whereas the latter showed an antibody titer of ≥512. S1-ELISA was not sensitive compared to other tests because only 16 serum samples were positive and they required an antibody titer of ≥64 in VSV-MERS/GFP. However, the sensitivity of S1-ELISA would be improved by examining the cut-off value and dilution of the test serum. In cELISA, five serum samples were negative out of the 31 positive samples in the neutralization tests, and an antibody titer of 16 was observed in both neutralization tests. Therefore, neutralization test using VSV-MERS/GFP exhibits sensitivity similar to the neutralization test using MERS-CoV and is more sensitive compared with the S1-ELISA as well as cELISA.
Search related documents:
Co phrase search for related documents- high correlation and neutralization test: 1, 2, 3, 4, 5
- high correlation and positive sample: 1, 2
- high correlation and serum sample: 1, 2
- high correlation and test compare: 1
- MERS CoV and neutralization test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- MERS CoV and positive sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- MERS CoV and serum sample: 1
- MERS CoV and test compare: 1
- MERS CoV and test serum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- MERS CoV and VSV MERS GFP MERS CoV: 1, 2, 3, 4, 5
- neutralization test and positive sample: 1, 2, 3, 4, 5, 6, 7
- neutralization test and serum sample: 1, 2, 3, 4, 5, 6, 7, 8
- neutralization test and test compare: 1, 2, 3
- neutralization test and test serum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- neutralization test and VSV MERS GFP MERS CoV: 1, 2, 3
- positive sample and serum sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- positive sample and test compare: 1, 2, 3
- positive sample and test serum: 1, 2, 3, 4, 5, 6, 7, 8, 9
- serum sample and test serum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
Co phrase search for related documents, hyperlinks ordered by date